Approval · Notice of Compliance 20264 · 2018
VELPHORO: Notice of Compliance 20264
Issued January 5, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20264
- Date
- January 5, 2018
- Company
- Vifor Fresenius Medical Care Renal Pharma LtdSt Gallen, St Gallen, Switzerland
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VELPHORO | 02471574 | Marketed |
Medicinal ingredients
- SUCROFERRIC OXYHYDROXIDE 2,500 MG per TAB